Literature DB >> 12045397

Cytochrome P450 pathways of arachidonic acid metabolism.

Deanna L Kroetz1, Darryl C Zeldin.   

Abstract

Cytochrome P450s metabolize arachidonic acid to hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids. These eicosanoids are formed in a tissue and cell-specific manner and have numerous biological functions. Of major interest are the opposing actions of hydroxyeicosatetraenoic and epoxyeicosatrienoic acids within the vasculature. Regio- and stereoisomeric epoxyeicosatrienoic acids have potent vasodilatory properties while 20-hydroxyeicosatetraenoic acid is a potent vasoconstrictor. Both effects are mediated through actions on large-conductance Ca2+-activated K+ channels. Cytochrome P450-derived eicosanoids are also important in the regulation of ion transport, and have recently been shown to influence a number of fundamental biological processes including cellular proliferation, apoptosis, inflammation, and hemostasis. The formation of these functionally relevant eicosanoids is tightly controlled by the expression and activity of the cytochrome P450 epoxygenases and hydroxylases. In addition, soluble epoxide hydrolase catalyzes the hydrolysis of epoxyeicosatrienoic acids to dihydroxyeicosatrienoic acids, and the activity of this enzyme is a critical determinant of tissue epoxyeicosatrienoic and dihydroxyeicosatrienoic acid levels. The intracellular balance between epoxyeicosatrienoic, dihydroxyeicosatrienoic and hydroxyeicosatetraenoic acids influences the biological response to these eicosanoids and alterations in their levels have recently been associated with certain pathological conditions. The involvement of the cytochrome P450-derived eicosanoids in a wide array of biological functions and the observation that levels are altered in pathological conditions suggest that the enzymes involved in the formation and degradation of these fatty acids may be novel therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045397     DOI: 10.1097/00041433-200206000-00007

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  58 in total

1.  Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth.

Authors:  Chen Chen; Xin Wei; Xiaoquan Rao; Jun Wu; Shenglan Yang; Fuqiong Chen; Ding Ma; Jianfeng Zhou; Ryan T Dackor; Darryl C Zeldin; Dao Wen Wang
Journal:  J Pharmacol Exp Ther       Date:  2010-10-28       Impact factor: 4.030

2.  20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2+ channel via a PKC-dependent mechanism in cardiomyocytes.

Authors:  Qinghua Zeng; Yong Han; Yuyan Bao; Wei Li; Xingting Li; Xin Shen; Xu Wang; Fanrong Yao; Stephen T O'Rourke; Chengwen Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-30       Impact factor: 4.733

Review 3.  Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.

Authors:  Cameron Rink; Savita Khanna
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

4.  Characterization of four new mouse cytochrome P450 enzymes of the CYP2J subfamily.

Authors:  Joan P Graves; Matthew L Edin; J Alyce Bradbury; Artiom Gruzdev; Jennifer Cheng; Fred B Lih; Tiwanda A Masinde; Wei Qu; Natasha P Clayton; James P Morrison; Kenneth B Tomer; Darryl C Zeldin
Journal:  Drug Metab Dispos       Date:  2013-01-11       Impact factor: 3.922

5.  Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway.

Authors:  Robert Fischer; Anne Konkel; Heidrun Mehling; Katrin Blossey; Andrej Gapelyuk; Niels Wessel; Clemens von Schacky; Ralf Dechend; Dominik N Muller; Michael Rothe; Friedrich C Luft; Karsten Weylandt; Wolf-Hagen Schunck
Journal:  J Lipid Res       Date:  2014-03-16       Impact factor: 5.922

6.  Epoxyeicosatrienoic acids prevent cisplatin-induced renal apoptosis through a p38 mitogen-activated protein kinase-regulated mitochondrial pathway.

Authors:  Yingmei Liu; Xiaodan Lu; Sinh Nguyen; Jean L Olson; Heather K Webb; Deanna L Kroetz
Journal:  Mol Pharmacol       Date:  2013-10-03       Impact factor: 4.436

7.  Soluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single Agent.

Authors:  Jeffrey J Iliff; Nabil J Alkayed
Journal:  Future Neurol       Date:  2009-03-01

8.  Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing.

Authors:  Yan Lu; Haibin Tian; Song Hong
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

9.  Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450.

Authors:  Danièle Lucas; Sophie Goulitquer; Jan Marienhagen; Maude Fer; Yvonne Dreano; Ulrich Schwaneberg; Yolande Amet; Laurent Corcos
Journal:  J Lipid Res       Date:  2009-11-25       Impact factor: 5.922

10.  Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo.

Authors:  Chen Chen; Guiling Li; Wanmin Liao; Jun Wu; Liu Liu; Ding Ma; Jianfeng Zhou; Reem H Elbekai; Matthew L Edin; Darryl C Zeldin; Dao Wen Wang
Journal:  J Pharmacol Exp Ther       Date:  2009-03-16       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.